Scientist-RCDiscoveryBiology

Fusion Pharmaceuticals, a member of the AstraZeneca Group, is advancing next generation radio conjugates as precision medicines for cancer. By combining Fusion’s deep radiopharmaceutical expertise with AstraZeneca’s global scale and reach, we are working to translate bold science into meaningful outcomes for patients. This is an opportunity to join a collaborative, innovation-driven team at the forefront of oncology research. We are seeking a highly motivated, hands-on **Scientist, Bioscience,** to support later-stage radio conjugate programs through assay development, pre-clinical profiling of mechanisms-of-action, and _in vitro_ drug-drug combination studies. This role is ideal for a strong laboratory scientist who thrives in a fast-paced research environment and enjoys working across disciplines to generate high-quality data that advances discovery and development programs. The successful candidate will contribute to the design, execution, analysis, and reporting of a broad range of cellular, molecular, and histological assays. Working closely with cross-functional colleagues in biology, _in vivo_ pharmacology and radiochemistry, this individual will provide cross-program support to advance targeted radio therapy development. **Accountabilities** * Independently executes routine _in vitro_ drug mechanism-of-action and cell viability experiments by applying techniques of cell and molecular biology (e.g. cell culture, flow cytometry, immunoblotting, immunofluorescence). Contributes to cell line model development (lentiviral transduction, CRISPR/Cas9), and mammalian tissue processing or analysis (e.g. immunohistochemistry, immunoblotting, RNA/DNA sequencing sample preparation). * Communicates the results to team members and is involved in the interpretation of data. * Supports a team and works collaboratively with project managers to ensure the efficient relay of information and forward translation of data. * Maintains a well-developed understanding of approaches to